Lehigh Center for Clinical Research Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00813735
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Lehigh Center for Clinical Research, Allentown PA

Active Ingredients

Drugs in Phase 4 Trials (2)

escitalopram (lexapro) (1 trial)

eszopiclone (lunesta) (1 trial)

Drugs in Phase 2 Trials (1)

rapastinel (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 3